USD 16.94
(0.01%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 152.84 Billion JPY | 0.31% |
2023 | 147.87 Billion JPY | 1.0% |
2022 | 146.41 Billion JPY | 6.52% |
2021 | 137.45 Billion JPY | 18.31% |
2020 | 116.17 Billion JPY | 31.62% |
2019 | 88.26 Billion JPY | 40.45% |
2018 | 62.84 Billion JPY | -4.55% |
2017 | 65.84 Billion JPY | -19.31% |
2016 | 81.59 Billion JPY | -9.69% |
2015 | 90.35 Billion JPY | 6.53% |
2014 | 84.81 Billion JPY | 1.48% |
2013 | 83.57 Billion JPY | -10.46% |
2012 | 93.34 Billion JPY | 101.67% |
2011 | 46.28 Billion JPY | 10.92% |
2010 | 41.72 Billion JPY | 12.79% |
2009 | 36.99 Billion JPY | -13.05% |
2008 | 42.54 Billion JPY | 8.33% |
2007 | 39.27 Billion JPY | -16.18% |
2006 | 46.85 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 FY | 152.84 Billion JPY | 3.36% |
2024 Q2 | 134.44 Billion JPY | -3.83% |
2024 Q1 | 139.8 Billion JPY | -5.46% |
2024 Q4 | 152.84 Billion JPY | 8.48% |
2024 Q3 | 140.9 Billion JPY | 4.8% |
2023 Q3 | 127.15 Billion JPY | -1.15% |
2023 Q1 | 132.27 Billion JPY | -9.66% |
2023 Q4 | 147.87 Billion JPY | 16.3% |
2023 FY | 147.87 Billion JPY | 1.0% |
2023 Q2 | 128.63 Billion JPY | -2.75% |
2022 Q1 | 131.75 Billion JPY | -4.15% |
2022 Q3 | 143.39 Billion JPY | 1.95% |
2022 FY | 146.41 Billion JPY | 6.52% |
2022 Q2 | 140.65 Billion JPY | 6.76% |
2022 Q4 | 146.41 Billion JPY | 2.1% |
2021 Q3 | 135.75 Billion JPY | 8.55% |
2021 Q1 | 116.25 Billion JPY | 0.07% |
2021 Q4 | 137.45 Billion JPY | 1.25% |
2021 Q2 | 125.05 Billion JPY | 7.57% |
2021 FY | 137.45 Billion JPY | 18.31% |
2020 Q4 | 116.17 Billion JPY | 11.19% |
2020 FY | 116.17 Billion JPY | 31.62% |
2020 Q1 | 87.63 Billion JPY | -0.71% |
2020 Q2 | 84.56 Billion JPY | -3.5% |
2020 Q3 | 104.48 Billion JPY | 23.55% |
2019 Q1 | 101.73 Billion JPY | 61.88% |
2019 Q2 | 81.82 Billion JPY | -19.57% |
2019 Q4 | 88.26 Billion JPY | 2.61% |
2019 FY | 88.26 Billion JPY | 40.45% |
2019 Q3 | 86.01 Billion JPY | 5.13% |
2018 Q2 | 64.52 Billion JPY | 5.05% |
2018 FY | 62.84 Billion JPY | -4.55% |
2018 Q4 | 62.84 Billion JPY | 18.17% |
2018 Q3 | 53.18 Billion JPY | -17.58% |
2018 Q1 | 61.42 Billion JPY | -6.71% |
2017 Q2 | 81.67 Billion JPY | 2.34% |
2017 FY | 65.84 Billion JPY | -19.31% |
2017 Q3 | 80.04 Billion JPY | -1.99% |
2017 Q1 | 79.81 Billion JPY | -2.19% |
2017 Q4 | 65.84 Billion JPY | -17.75% |
2016 Q2 | 88.32 Billion JPY | -1.11% |
2016 Q4 | 81.59 Billion JPY | -4.07% |
2016 Q3 | 85.06 Billion JPY | -3.7% |
2016 FY | 81.59 Billion JPY | -9.69% |
2016 Q1 | 89.31 Billion JPY | -1.15% |
2015 Q2 | 80.75 Billion JPY | 2.64% |
2015 Q1 | 78.67 Billion JPY | -7.24% |
2015 Q3 | 79.88 Billion JPY | -1.07% |
2015 Q4 | 90.35 Billion JPY | 13.1% |
2015 FY | 90.35 Billion JPY | 6.53% |
2014 Q1 | 79.24 Billion JPY | -5.19% |
2014 FY | 84.81 Billion JPY | 1.48% |
2014 Q3 | 80.73 Billion JPY | 0.89% |
2014 Q4 | 84.81 Billion JPY | 5.06% |
2014 Q2 | 80.02 Billion JPY | 0.98% |
2013 Q3 | 86.42 Billion JPY | 4.82% |
2013 Q4 | 83.57 Billion JPY | -3.29% |
2013 FY | 83.57 Billion JPY | -10.46% |
2013 Q1 | 86.96 Billion JPY | -6.83% |
2013 Q2 | 82.45 Billion JPY | -5.19% |
2012 FY | 93.34 Billion JPY | 101.67% |
2012 Q2 | 43.97 Billion JPY | -0.1% |
2012 Q3 | 89.5 Billion JPY | 103.54% |
2012 Q4 | 93.34 Billion JPY | 4.29% |
2012 Q1 | 44.01 Billion JPY | -4.9% |
2011 Q1 | 43.16 Billion JPY | 3.43% |
2011 FY | 46.28 Billion JPY | 10.92% |
2011 Q2 | 49.09 Billion JPY | 13.75% |
2011 Q3 | 44.14 Billion JPY | -10.08% |
2011 Q4 | 46.28 Billion JPY | 4.85% |
2010 Q2 | 37.15 Billion JPY | 0.0% |
2010 FY | 41.72 Billion JPY | 12.79% |
2010 Q4 | 41.72 Billion JPY | 13.79% |
2010 Q3 | 36.67 Billion JPY | -1.32% |
2009 Q3 | 33.05 Billion JPY | 0.0% |
2009 Q4 | 36.99 Billion JPY | 11.92% |
2009 FY | 36.99 Billion JPY | -13.05% |
2008 FY | 42.54 Billion JPY | 8.33% |
2007 FY | 39.27 Billion JPY | -16.18% |
2006 FY | 46.85 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
American Bio Medica Corporation | 3.6 Million USD | -4236291.353% |
Arrayit Corporation | 7.49 Million USD | -2038812.877% |
Atlantic International Corp. | 3.82 Million USD | -3992176.064% |
Biocept, Inc. | 22.01 Million USD | -694257.879% |
Bioqual, Inc. | 18.93 Million USD | -807002.592% |
CardioGenics Holdings Inc | 1.79 Million USD | -8515529.918% |
DermTech, Inc. | 64.75 Million USD | -235942.008% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | -20696.538% |
HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -1233950.689% |
iMD Companies, Inc. | 1.67 Million USD | -9129486.624% |
IDenta Corp. | 1.01 Million USD | -15086293.238% |
Interpace Biosciences, Inc. | 28.15 Million USD | -542745.474% |
Integrative Health Technologies, Inc. | 297.94 Thousand USD | -51300634.694% |
InVitro International | 78.99 Thousand USD | -193504141.043% |
Lumos Diagnostics Holdings Limited | 19.72 Million USD | -774642.804% |
Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -118215326.499% |
Medical Imaging Corp. | 9.51 Million USD | -1605948.322% |
NovelStem International Corp. | 4.2 Million USD | -3633902.119% |
Optigenex Inc. | 9.57 Million USD | -1596964.934% |
PharmChem, Inc. | 558.64 Thousand USD | -27360469.376% |
Proteome Sciences plc | 18.48 Million USD | -826600.038% |
Response Genetics, Inc | 15.86 Million USD | -963213.796% |
Rennova Health, Inc. | 49.66 Million USD | -307645.43% |
RushNet, Inc. | 6.23 Million USD | -2449798.958% |
ScreenPro Security Inc. | 1.6 Million USD | -9549459.006% |
Stella Diagnostics Inc. | 18 Million USD | -848806.203% |
StageZero Life Sciences Ltd. | 8.2 Million USD | -1863005.862% |
Todos Medical Ltd. | 50.15 Million USD | -304641.113% |